Medical Trade Fair Offers Global Platform for UK Companies
|
By Flavio Steinbach, contributing writer Posted on 13 Nov 2017 |
|
Image: The ABHI will travel with 120 UK companies to the MEDICA trade show in Germany (Photo courtesy of the ABHI).
The Association of British Healthcare Industries (ABHI) (London, UK) will be taking 120 UK companies to MEDICA 2017, the world's leading medical trade fair taking place in Düsseldorf, Germany, from November 13 to 16, 2017. This highlights the desire within the UK to forge deeper, more sustainable trading relationships as the country navigates its departure from the EU.
MEDICA is attended by 132,000 specialist visitors from over 120 countries and offers a global platform for companies showcasing their innovative technologies. It also provides a strong platform for delegates to meet with distributors and buyers from around the world to discuss business with existing contacts and to meet with industry peers.
With the UK entering a new era for trade and business, its government has highlighted MedTech, and the broader Life Sciences sector, as playing a critical role in its Industrial Strategy - to propel UK productivity once it leaves the European Union. MedTech is now worth over GBP 17 billion to the UK and is part of a GBP 64 billion UK Life Sciences industry. A recent report titled ‘The Life Sciences Industrial Strategy’ has been welcomed by senior government ministers, and provides the framework for increased funding and support for the sector.
ABHI, the industry association for the medical technology sector in the UK, focuses on championing the benefits and use of safe and effective medical technologies to deliver high quality patient outcomes. With over 260 members, including leading multinational businesses and small and medium sized enterprises (SMEs) in the UK, ABHI leads the advocacy of the industry in order to advance access to medical technology.
In addition to supporting the UK’s exports globally, the ABHI is also keen on speaking with international companies wanting to do business within the UK. Their international membership has been set up to make it more accessible for global companies wishing to partner with their British counterparts.
“The UK is open for business and is keen to forge global healthcare links. With 120 companies exhibiting, we are delighted that the UK Pavilion is at its capacity,” said Paul Benton, Managing Director of International at ABHI. “The technology on show is a wonderful expression of what the industry has to offer in providing value-based healthcare solutions for patients across the globe.”
Related Links:
Association of British Healthcare Industries
MEDICA is attended by 132,000 specialist visitors from over 120 countries and offers a global platform for companies showcasing their innovative technologies. It also provides a strong platform for delegates to meet with distributors and buyers from around the world to discuss business with existing contacts and to meet with industry peers.
With the UK entering a new era for trade and business, its government has highlighted MedTech, and the broader Life Sciences sector, as playing a critical role in its Industrial Strategy - to propel UK productivity once it leaves the European Union. MedTech is now worth over GBP 17 billion to the UK and is part of a GBP 64 billion UK Life Sciences industry. A recent report titled ‘The Life Sciences Industrial Strategy’ has been welcomed by senior government ministers, and provides the framework for increased funding and support for the sector.
ABHI, the industry association for the medical technology sector in the UK, focuses on championing the benefits and use of safe and effective medical technologies to deliver high quality patient outcomes. With over 260 members, including leading multinational businesses and small and medium sized enterprises (SMEs) in the UK, ABHI leads the advocacy of the industry in order to advance access to medical technology.
In addition to supporting the UK’s exports globally, the ABHI is also keen on speaking with international companies wanting to do business within the UK. Their international membership has been set up to make it more accessible for global companies wishing to partner with their British counterparts.
“The UK is open for business and is keen to forge global healthcare links. With 120 companies exhibiting, we are delighted that the UK Pavilion is at its capacity,” said Paul Benton, Managing Director of International at ABHI. “The technology on show is a wonderful expression of what the industry has to offer in providing value-based healthcare solutions for patients across the globe.”
Related Links:
Association of British Healthcare Industries
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Pediatric Mask
Respire SOFT
New
Gas Analyzer
GE SAM
Latest Medica 2017 News
- TRILUX Medical and Mizuho to Showcase New Modular OR Solutions
- Richard Wolf to Present Innovative System Solutions at Germany Trade Show
- Randox to Showcase Future-Proofing Diagnostic Technology at Trade Fair
- PROTEC to Launch New Motorized PRS 500 B X-ray System
- NDS Announces New OR Networking Solution at Germany Trade Show
- Global Good and Motic Announce AI-Powered Microscope at MEDICA 2017
- LG Unveils Expanded Medical Imaging Product Lineup
- AE Adam to Exhibit Balances and Moisture Analyzers at Medical Fair
- Rober Showcases Pressure Mattress Solutions at MEDICA
- Single-Use Needle with Suction Launched at MEDICA Trade Show
- MEDICA 2017 Welcomes 5000+ Exhibitors from 68 Countries
Channels
Artificial Intelligence
view channel
AI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
Critical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
Surgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
